Skip to main content

Table 1 ATC4, generic name, and DDD of antihypertensive drugs

From: Relationship between antihypertensive drug use and number of people with high blood pressure in FY 2018: a descriptive epidemiological study based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan open data

Mechanism of action

ATC4*1

Generic name

DDD*2 (g)

Phosphodiesterase inhibitors

B01AC

Dipyridamole

0.400

Organic nitrates

C01DA

Isosorbide mononitrate

Isosorbide dinitrate

0.040

0.060

Other vasodilators used in cardiac diseases

C01DX

Dilazep

Nicorandil

0.100

0.040

Methyldopa

C02AB

Methyldopa

1.000

Alpha-adrenoreceptor antagonists

C02CA

Doxazosin

Urapidil

0.004

0.120

Sulfonamides, plain

C03BA

Indapamide

0.003

Aldosterone antagonists

C03DA

Eplerenone

0.050

Beta-blocking agents, selective

C07AB

Metoprolol

0.150

Alpha- and beta-blocking agents

C07AG

Carvedilol

0.038

Dihydropyridine derivatives

C08CA

Amlodipine

Azelnidipine

Benidipine

Cilnidipine

Efonidipine

Nifedipine

0.005

0.016*3

0.004*3

0.010

0.040*3

0.030

Phenylalkylamine derivatives

C08DA

Verapamil

0.240

Benzothiazepine derivatives

C08DB

Diltiazem

0.240

ACE*4 inhibitors, plain

C09AA

Enalapril

Imidapril

0.010

0.010

ARBs*5, plain

C09CA

Azilsartan

Candesartan

Irbesartan

Losartan

Olmesartan medoxomil

Telmisartan

Valsartan

0.040

0.008

0.150

0.050

0.020

0.040

0.080

ARBs*5 and diuretics

C09DA

Candesartan and diuretics

Losartan and diuretics

Telmisartan and diuretics

Valsartan and diuretics

1 UD *6

ARBs*5 and calcium channel blockers

C09DB

Azilsartan and Amlodipine

Candesartan and Amlodipine

Irbesartan and Amlodipine

Olmesartan medoxomil and Azelnidipine

Telmisartan and Amlodipine

Valsartan and Amlodipine

Valsartan and Cilnidipine

  1. *1 ATC Anatomical Therapeutic Chemical, *2 DDD Defined daily dose, *3 DDD is not listed in the ATC/DDD Index 2023 and is defined from the dosage and administration in the package insert. *4 ACE angiotensin-converting enzyme inhibitor, *5 ARB angiotensin II receptor blocker, *6 UD Unit of combination drug